Edition:
United Kingdom

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

63.48EUR
23 Feb 2018
Change (% chg)

€-0.18 (-0.28%)
Prev Close
€63.66
Open
€63.84
Day's High
€63.90
Day's Low
€62.98
Volume
912,254
Avg. Vol
1,582,542
52-wk High
€80.07
52-wk Low
€60.15

Select another date:

Sun, Jan 7 2018

Photo

Fresenius CFO backs acquisition course - Boersen-Zeitung

FRANKFURT German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

Fresenius CFO backs acquisition course: Boersen-Zeitung

FRANKFURT German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

Fresenius CFO backs acquisition course -Boersen-Zeitung

FRANKFURT, Jan 7 German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

BRIEF-Fresenius says US Tax Reform ‍results In One-Time Book Gain Of about 90 mln euros

* ‍NEW US TAX LEGISLATION TRIGGERS REVALUATION OF DEFERRED TAX LIABILITIES​

Fresenius says on track to increase dividend again next year

FRANKFURT, Nov 21 German healthcare group Fresenius SE is well on its way to further increase its annual dividend next year, reflecting the prospect of earnings growth in 2017, its chief executive said.

Senvest Management shorting drug stocks Insys, Akorn, Fresenius

TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,

Select another date: